Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02279888 · ClinicalTrials.gov registry record
CardioMEMS HF System Post Approval Study
A clinical trial of Heart Failure and Congestive Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,214
- Enrollment target
- 1
- Study location
NCT02279888: Completed study of Heart Failure and Congestive Heart Failure, sponsored by Abbott Medical Devices.
NCT02279888 is a study of Heart Failure and Congestive Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,214 participants, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02279888, a study of Heart Failure and Congestive Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,214 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the CardioMEMS HF System Post Approval Study (PAS) is to evaluate the use of the CardioMEMS HF System in patients with NYHA class III heart failure in a commercial setting.
Primary Outcome
As defined in the study protocol, a DSRC is an adverse event that is, or is possibly, related to the device/system (wireless pressure sensor or external electronics) and has at least one of the following characteristics: is treated with invasive means (other than intramuscular medication or right heart catheterization which is used for diagnostic purposes); results in death of the subject; results in the explant of the device. The primary safety analyses were based on the following objective per
Conditions Studied
Interventions
- DEVICE CardioMEMS HF System
Study Locations (1)
West Virginia
- West Virginia Heart Institute - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,214 participants |
| Start Date | 2015-01 |
| Est. Completion | 2019-10-11 |
What the finished NCT02279888 record still lists
NCT02279888 is an observational study that tracks outcomes without assigning an intervention. Its 1,214 participants enrollment target places it among the larger protocols in the corpus, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (41% lower).
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CardioMEMS HF System is the first listed.
NCT02279888 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT02279888 about?
NCT02279888 is a clinical study titled "CardioMEMS HF System Post Approval Study". The purpose of the CardioMEMS HF System Post Approval Study (PAS) is to evaluate the use of the CardioMEMS HF System in patients with NYHA class III heart failure in a commercial setting.
What is the current status of trial NCT02279888?
This trial is currently completed. The enrollment target is 1,214 participants. The study started on 2015-01. Estimated completion is 2019-10-11.
What conditions does trial NCT02279888 study?
This clinical trial studies the following conditions: Heart Failure, Congestive Heart Failure, Left-Sided Heart Failure.
What interventions are being tested in trial NCT02279888?
The interventions under investigation include: CardioMEMS HF System (DEVICE).
Who is sponsoring clinical trial NCT02279888?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02279888 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02279888's enrollment target sits among peer trials
1,214 63rd of 397 higher than 335 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05827016 · 1,216 participants · Phase 3
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
- NCT06143956 · 1,217 participants · Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- NCT05946213 · 1,209 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia